The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Self-citationStructure of the human class I histocompatibility antigen, HLA-A2
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,472
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W.-J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305133 · Cited by 3,392
Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812223192527 · Cited by 2,389
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329512a0 · Cited by 2,377
ZINKERNAGEL, R. M., & DOHERTY, P. C. (1974) · Nature · doi:10.1038/248701a0 · Cited by 2,095
Townsend, A. (1986) · Cell · doi:10.1016/0092-8674(86)90019-x · Cited by 1,699
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Weber, J. S., Kähler, K. C., & Hauschild, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.6750 · Cited by 1,415
Long term culture of tumour-specific cytotoxic T cells
GILLIS, S., & SMITH, K. A. (1977) · Nature · doi:10.1038/268154a0 · Cited by 1,386
Parker, K. C., Bednarek, M. A., & Coligan, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.163 · Cited by 1,370
BRUNNER, K. T., Mauël, J., Cerottini, J. C., & Chapuis, B. (1968) · PubMed Central · Cited by 1,367
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
Chen, Y.-T., Scanlan, M. J., Sahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., & Old, L. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1914 · Cited by 1,247
Immunity to Methylcholanthrene-Induced Sarcomas
(1957) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/18.6.769 · Cited by 1,229
Linette, G. P., Stadtmauer, E. A., Maus, M. V., Rapoport, A. P., Levine, B. L., Emery, L., Litzky, L., Bagg, A., Carreno, B. M., Cimino, P. J., et al. (2013) · Blood · doi:10.1182/blood-2013-03-490565 · Cited by 1,179
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Morgan, R. A., Chinnasamy, N., Abate-Daga, D., Gros, A., Robbins, P. F., Zheng, Z., Dudley, M. E., Feldman, S. A., Yang, J. C., Sherry, R. M., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182829903 · Cited by 1,148
Cell-Mediated Cytotoxicity, Allograft Rejection, and Tumor Immunity
Cerottini, J.-C., & Brunner, K. T. (1974) · Advances in Immunology · doi:10.1016/s0065-2776(08)60308-9 · Cited by 1,141
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3515 · Cited by 1,092
Human neoplasms elicit multiple specific immune responses in the autologous host.
Sahin, U., Türeci, O., Schmitt, H., Cochlovius, B., Johannes, T., Schmits, R., Stenner, F., Luo, G., Schobert, I., & Pfreundschuh, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11810 · Cited by 1,078
Parkhurst, M. R., Yang, J. C., Langan, R. C., Dudley, M. E., Nathan, D.-A. N., Feldman, S. A., Davis, J. L., Morgan, R. A., Merino, M. J., Sherry, R. M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.272 · Cited by 1,020
Brichard, V, Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., & Boon, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.489 · Cited by 950
Self-citationLamers, C. H. J., Sleijfer, S., Vulto, A. G., Kruit, W. H. J., Kliffen, M., Debets, R., Gratama, J. W., Stoter, G., & Oosterwijk, E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9964 · Cited by 915
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6458 · Cited by 914
Coulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
Self-citationKawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., & Rosenberg, S. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.347 · Cited by 862
Adoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., & Slingluff, C. L. (1994) · Science · doi:10.1126/science.7513441 · Cited by 824
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., & Rammensee, H.-G. (1990) · Nature · doi:10.1038/348252a0 · Cited by 769
Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., & Boon, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.921 · Cited by 762
Self-citationJäger, E., Chen, Y.-T., Drijfhout, J. W., Karbach, J., Ringhoffer, M., Jäger, D., Arand, M., Wada, H., Noguchi, Y., Stockert, E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.265 · Cited by 725
Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
Self-citationHUMAN T CELL RESPONSES AGAINST MELANOMA
Boon, T., Coulie, P. G., Eynde, B. J. V. D., & Bruggen, P. V. D. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090733 · Cited by 651
Self-citationCancer Immunotherapy: A Treatment for the Masses
Blattman, J. N., & Greenberg, P. D. (2004) · Science · doi:10.1126/science.1100369 · Cited by 612
Thymus-Marrow Cell Combinations. Synergism in Antibody Production.
Claman, H. N., Chaperon, E. A., & Triplett, R. F. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-122-31353 · Cited by 610
Structure, chromosomal localization, and expression of 12 genes of the MAGE family
De Plaen, E., Traversari, C., Gaforio, J. J., Szikora, J.-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Chomez, P., et al. (1994) · Immunogenetics · doi:10.1007/bf01246677 · Cited by 586
Self-citationBAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
Boël, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J.-C., Coulie, P., Boon, T., & van der Bruggen, P. (1995) · Immunity · doi:10.1016/s1074-7613(95)80053-0 · Cited by 583
Self-citationAn overview of the MAGE gene family with the identification of all human members of the family.
Chomez, P., Backer, O. D., Bertrand, M. J. M., Plaen, E. D., Boon, T., & Lucas, S. (2001) · PubMed · Cited by 573
Self-citationVan den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., & Boon, T. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.689 · Cited by 567
Self-citationRobbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1185 · Cited by 550
Fisk, B., Blevins, T. L., Wharton, J. T., & Ioannides, C. G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2109 · Cited by 543
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., & Boon, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7149 · Cited by 542
Self-citationRomero, P., Rod Dunbar, P., Valmori, D., Pittet, M., Ogg, G. S., Rimoldi, D., Chen, J.-L., Liénard, D., Cerottini, J.-C., & Cerundolo, V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1641 · Cited by 521
Pittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D. E., Liénard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J.-C., & Romero, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.705 · Cited by 508
Tsang, K. Y., Zaremba, S., Nieroda, C. A., Zhu, M. Z., Hamilton, J. M., & Schlom, J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.13.982 · Cited by 498
Hewitt, H. B., Blake, E. R., & Walder, A. S. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.37 · Cited by 474
Van Tendeloo, V. F. I., Ponsaerts, P., Lardon, F., Nijs, G., Lenjou, M., Van Broeckhoven, C., Van Bockstaele, D. R., & Berneman, Z. N. (2001) · Blood · doi:10.1182/blood.v98.1.49 · Cited by 468
MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
Doyle, J. M., Gao, J., Wang, J., Yang, M., & Potts, P. R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.029 · Cited by 467
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
Lennerz, V., Fatho, M., Gentilini, C., Frye, R. A., Lifke, A., Ferel, D., Wölfel, C., Huber, C., & Wölfel, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500090102 · Cited by 456
Immune resistance orchestrated by the tumor microenvironment
Gajewski, T. F., Meng, Y., Blank, C., Brown, I., Kacha, A., Kline, J., & Harlin, H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00442.x · Cited by 437
Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., & Boon, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7976 · Cited by 423
Self-citationMorel, S., Lévy, F., Burlet-Schiltz, O., Brasseur, F., Probst-Kepper, M., Peitrequin, A.-L., Monsarrat, B., Van Velthoven, R., Cerottini, J.-C., Boon, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80163-6 · Cited by 415
Self-citationTwo tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes
Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Zum Büschenfelde, K. M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240340 · Cited by 411
Self-citationSkipper, J. C., Hendrickson, R. C., Gulden, P. H., Brichard, V, Van Pel, A., Chen, Y., Shabanowitz, J., Wolfel, T., Slingluff, C. L., Boon, T., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.527 · Cited by 405
Self-citationTumor‐specific shared antigenic peptides recognized by human T cells
Van Der Bruggen, P., Zhang, Y., Chaux, P., Stroobant, V., Panichelli, C., Schultz, E. S., Chapiro, J., Van den Eynde, B. J., Brasseur, F., & Boon, T. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18806.x · Cited by 378
Self-citationAberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia
Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., et al. (1997) · Blood · doi:10.1182/blood.v89.4.1405 · Cited by 371
van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241218 · Cited by 367
Self-citationIntradermal Immunization of C3H Mice against a Sarcoma That Originated in an Animal of the Same Line
Gross, L. (1943) · Cancer Research · Cited by 360
Gotter, J., Brors, B., Hergenhahn, M., & Kyewski, B. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031677 · Cited by 359
Ohminami, H., Yasukawa, M., & Fujita, S. (2000) · Blood · doi:10.1182/blood.v95.1.286 · Cited by 347
Immune recognition of a human renal cancer antigen through post-translational protein splicing
Hanada, K.-I., Yewdell, J. W., & Yang, J. C. (2004) · Nature · doi:10.1038/nature02240 · Cited by 336
MHC Ligands and Peptide Motifs
Rammensee, H.-G., Bachmann, J., & Stevanović, S. (1997) · Molecular Biology Intelligence Unit · doi:10.1007/978-3-662-22162-4 · Cited by 331
An Antigenic Peptide Produced by Peptide Splicing in the Proteasome
Vigneron, N., Stroobant, V., Chapiro, J., Ooms, A., Degiovanni, G., Morel, S., van der Bruggen, P., Boon, T., & Van den Eynde, B. J. (2004) · Science · doi:10.1126/science.1095522 · Cited by 330
Self-citationA CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma
Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., & Bruggen, P. V. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.785 · Cited by 321
Self-citationBoczkowski, D., Nair, S. K., Nam, J., Lyerly, H. K., & Gilboa, E. (2000) · PubMed · Cited by 313
Chapuis, A. G., Ragnarsson, G. B., Nguyen, H. N., Chaney, C. N., Pufnock, J. S., Schmitt, T. M., Duerkopp, N., Roberts, I. M., Pogosov, G. L., Ho, W. Y., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004916 · Cited by 311
De Plaen, E., Lurquin, C., Van Pel, A., Mariamé, B., Szikora, J. P., Wölfel, T., Sibille, C., Chomez, P., & Boon, T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2274 · Cited by 308
Self-citationLurquin, C., Van Pel, A., Mariamé, B., De Plaen, E., Szikora, J.-P., Janssens, C., Reddehase, M. J., Lejeune, J., & Boon, T. (1989) · Cell · doi:10.1016/0092-8674(89)90844-1 · Cited by 300
Self-citationVan den Eynde, B., Lethé, B., Van Pel, A., De Plaen, E., & Boon, T. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1373 · Cited by 298
Self-citationWeber, J. S., Salgaller, M. L., Samid, D., Johnson, B., Herlyn, M., Lassam, N. J., Treisman, J. S., & Rosenberg, S. A. (1994) · PubMed · Cited by 294
Topalian, S. L., Rivoltini, L., Mancini, M., Markus, N. R., Robbins, P. F., Kawakami, Y., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9461 · Cited by 286
Yang, B., O'Herrin, S. M., Wu, J., Reagan-Shaw, S., Ma, Y., Bhat, K. M. R., Gravekamp, C., Setaluri, V., Peters, N., Hoffmann, F. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1478 · Cited by 272
LAGE-1, a new gene with tumor specificity
Lethé, B., Lucas, S., Michaux, L., Smet, C. D., Godelaine, D., Serrano, A., Plaen, E. D., & Boon, T. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980610)76:6<903::aid-ijc22>3.0.co;2-1 · Cited by 264
Self-citationCorreale, P., Nieroda, C., Zaremba, S., Zhu, M., Schlom, J., Tsang, K. Y., & Konstantin, W. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.4.293 · Cited by 264
Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
Topalian, S. L., Gonzales, M. I., Parkhurst, M., Li, Y. F., Southwood, S., Sette, A., Rosenberg, S. A., & Robbins, P. F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.1965 · Cited by 257
Monte, M., Simonatto, M., Peche, L. Y., Bublik, D. R., Gobessi, S., Pierotti, M. A., Rodolfo, M., & Schneider, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510834103 · Cited by 257
Wang, R. F., Parkhurst, M. R., Kawakami, Y., Robbins, P. F., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1131 · Cited by 255
Türeci, Ö., Şahin, U., Schobert, I., Koslowski, M., Scmitt, H., Schild, H., Stenner, F., Seitz, G., Rammensee, H., & Pfreundschuh, M. G. (1996) · PubMed · Cited by 249
Uyttenhove, C., Maryanski, J., & Boon, T. (1983) · The Journal of experimental medicine · doi:10.1084/jem.157.3.1040 · Cited by 245
Self-citationCilloni, D., Gottardi, E., De Micheli, D., Serra, A., Volpe, G., Messa, F., Rege-Cambrin, G., Guerrasio, A., Divona, M., Lo Coco, F., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402675 · Cited by 245
Lurquin, C., Lethé, B., De Plaen, E., Corbière, V., Théate, I., van Baren, N., Coulie, P. G., & Boon, T. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041378 · Cited by 240
Self-citationYotnda, P., Firat, H., Garcia-Pons, F., Garcia, Z., Gourru, G., Vernant, J. P., Lemonnier, F. A., Leblond, V, & Langlade-Demoyen, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci488 · Cited by 238
Knuth, A., Danowski, B., Oettgen, H. F., & Old, L. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3511 · Cited by 236
Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes
Chaux, P., Vantomme, V., Stroobant, V., Thielemans, K., Corthals, J., Luiten, R., Eggermont, A. M. M., Boon, T., & van der Bruggen, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.767 · Cited by 234
Self-citationGermeau, C., Ma, W., Schiavetti, F., Lurquin, C., Henry, E., Vigneron, N., Brasseur, F., Lethé, B., De Plaen, E., Velu, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041379 · Cited by 232
Self-citationMUC1 Immunobiology: From Discovery to Clinical Applications
Vlad, A. M., Kettel, J. C., Alajez, N. M., Carlos, C. A., & Finn, O. J. (2004) · Advances in Immunology · doi:10.1016/s0065-2776(04)82006-6 · Cited by 230
Guilloux, Y., Lucas, S., Brichard, V. G., Van Pel, A., Viret, C., De Plaen, E., Brasseur, F., Lethé, B., Jotereau, F., & Boon, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1173 · Cited by 230
Self-citationGuillaume, B., Chapiro, J., Stroobant, V., Colau, D., Van Holle, B., Parvizi, G., Bousquet-Dubouch, M.-P., Théate, I., Parmentier, N., & Van den Eynde, B. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009778107 · Cited by 216
Self-citationLucas, S., Smet, C. D., Arden, K. C., Viars, C. S., Lethé, B., Lurquin, C., & Boon, T. (1998) · PubMed · Cited by 210
Self-citationAn IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus
Giraud, M., Taubert, R., Vandiedonck, C., Ke, X., Lévi-Strauss, M., Pagani, F., Baralle, F. E., Eymard, B., Tranchant, C., Gajdos, P., et al. (2007) · Nature · doi:10.1038/nature06066 · Cited by 194
Quaglino, P., Marenco, F., Osella-Abate, S., Cappello, N., Ortoncelli, M., Salomone, B., Fierro, M. T., Savoia, P., & Bernengo, M. G. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp325 · Cited by 186
Enumeration of human antigen–specific naive CD8+ T cells reveals conserved precursor frequencies
Alanio, C., Lemaitre, F., Law, H. K. W., Hasan, M., & Albert, M. L. (2010) · Blood · doi:10.1182/blood-2009-10-251124 · Cited by 178
Klein, G., & Klein, E. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.5.2121 · Cited by 168
Chapiro, J., Claverol, S., Piette, F., Ma, W., Stroobant, V., Guillaume, B., Gairin, J.-E., Morel, S., Burlet-Schiltz, O., Monsarrat, B., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.1053 · Cited by 160
Self-citationThaete, C., Brett, D., Monaghan, P., Whitehouse, S. K., Rennie, G. R., Rayner, E. L., Cooper, C. S., & Goodwin, G. H. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.585 · Cited by 157
Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans
Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., Smedt, M. D., Guillaume, P., Ellefsen, K., Valmori, D., Líénard, D., Plum, J. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011658 · Cited by 156
Chaux, P., Luiten, R. M., Demotte, N., Vantomme, V., Stroobant, V., Traversari, C., Russo, V. E. A., Schultz, E. S., Cornelis, G. R., Boon, T., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2928 · Cited by 156
Self-citationSibille, C., Chomez, P., Wildmann, C., et al. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.1.35 · Cited by 151
Bai, S., He, B., & Wilson, E. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1238-1257.2005 · Cited by 151
Lonchay, C., van der Bruggen, P., Connerotte, T., Hanagiri, T., Coulie, P. G., Colau, D., Lucas, S., Pel, A. V., Thielemans, K., van Baren, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405743101 · Cited by 149
Self-citationBoon, T., & Kellermann, O. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.1.272 · Cited by 148
Self-citationLupetti, R., Pisarra, P., Verrecchia, A., Farina, C., Nicolini, G., Anichini, A., Bordignon, C., Sensi, M., Parmiani, G., & Traversari, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1005 · Cited by 146
Brändle, D., Brasseur, F., Weynants, P., Boon, T., & den Eynde, B. J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2501 · Cited by 144
Self-citationYang, R., Roberta Morosetti, A., & Koeffler, H. P. (1997) · PubMed · Cited by 143
Gambacorti-Passerini, C. B., Grignani, F., Arienti, F., Pandolfi, P. P., Pelicci, P. G., & Parmiani, G. (1993) · Blood · doi:10.1182/blood.v81.5.1369.1369 · Cited by 140
Lim, F.-L., Soulez, M., Koczan, D., Thiesen, H., & Knight, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202122 · Cited by 140
Therapeutic vaccination against human papilloma virus induced malignancies
van der Burg, S. H., & Melief, C. J. M. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.12.010 · Cited by 139
Lurquin, C., Smet, C. D., Brasseur, F., Muscatelli, F., Martelange, V., Plaen, E. D., Brasseur, R., Monaco, A. P., & Boon, T. (1997) · Genomics · doi:10.1006/geno.1997.5052 · Cited by 139
Self-citationWheelock, Ε. F., Weinhold, K. J., & Levich, J. D. (1981) · Advances in cancer research · doi:10.1016/s0065-230x(08)60240-7 · Cited by 138
An antigenic peptide produced by reverse splicing and double asparagine deamidation
Dalet, A., Robbins, P. F., Stroobant, V., Vigneron, N., Li, Y. F., El‐Gamil, M., Hanada, K., Yang, J. C.-H., Rosenberg, S. A., & den Eynde, B. J. V. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101892108 · Cited by 137
den Eynde, B. J. V., Gaugler, B., Probst‐Kepper, M., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1793 · Cited by 134
Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma
Lim, S. H., Wang, Z., Chiriva‐Internati, M., et al. (2001) · Blood · doi:10.1182/blood.v97.5.1508 · Cited by 133
Selection of highly transfectable variant from mouse mastocytoma P815
Pel, A. V., Plaen, E. D., & Boon, T. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534840 · Cited by 131
Self-citationCoulie, P. G., Somville, M., Lehmann, F. F., Hainaut, P., Brasseur, F., Devos, R., & Boon, T. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500220 · Cited by 130
Self-citationHolm, G., & Perlmann, P. (1967) · PubMed · Cited by 127
Uyttenhove, C., Snick, J. V., & Boon, T. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.5.1175 · Cited by 126
Self-citationSchultz, E. S., Chapiro, J., Lurquin, C., Claverol, S., Burlet‐Schiltz, O., Warnier, G., Russo, V. E. A., Morel, S., Lévy, F., Boon, T., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011974 · Cited by 122
Self-citationLucas, S., Plaen, E. D., & Boon, T. (2000) · International Journal of Cancer · Cited by 122
Self-citationAyyoub, M., Stevanović, S., Şahin, U., Guillaume, P., Servis, C., Rimoldi, D., Valmori, D., Romero, P. J., Cerottini, J., Rammensee, H., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1717 · Cited by 121
Identification on a human sarcoma of two new genes with tumor-specific expression.
Martelange, V., Smet, C. D., Plaen, E. D., Lurquin, C., & Boon, T. (2000) · PubMed · Cited by 120
Self-citationThe Melanoma Antigen Gene (MAGE) Family Is Clustered in the Chromosomal Band Xq28
Rogner, U. C., Wilke, K., Steck, E., Korn, B., & Poustka, A. (1995) · Genomics · doi:10.1006/geno.1995.9945 · Cited by 117
Yotnda, P., Garcia, F., Peuchmaur, M. M., Grandchamp, B., Duval, M., Lemonnier, F. A., VILMER, E., & Langlade‐Demoyen, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3126 · Cited by 111
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes
Kessler, J. H., Khan, S., Seifert, U., Gall, S. L., Chow, K. M., Paschen, A., Bres-Vloemans, S. A., de Ru, A., van Montfoort, N., Franken, K. L. M. C., et al. (2010) · Nature Immunology · doi:10.1038/ni.1974 · Cited by 109
The Murine Sarcoma Virus-Induced Tumor: Exception or General Model in Tumor Immunology?
Lévy, J. P., & Leclerc, J. C. (1977) · Advances in cancer research · doi:10.1016/s0065-230x(08)61012-x · Cited by 108
MAGE-A4 Interacts with the Liver Oncoprotein Gankyrin and Suppresses Its Tumorigenic Activity
Nagao, T., Higashitsuji, H., Nonoguchi, K., Sakurai, T., Dawson, S. P., Mayer, R. J., Itoh, K., & Fujita, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206104200 · Cited by 108
Yeh, S., Karne, N. K., Kerkar, S. P., Heller, C. K., Palmer, D. C., Johnson, L. A., Li, Z., Bishop, R. J., Wong, W. T., Sherry, R. M., et al. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.12.004 · Cited by 107
Isolation and characterization of a MAGE gene family in the Xp21.3 region.
Muscatelli, F., Walker, A. P., Plaen, E. D., Stafford, A., & Monaco, A. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4987 · Cited by 103
Aarnoudse, C. A., van den Doel, P. B., Heemskerk, B., & Schrier, P. I. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990730)82:3<442::aid-ijc19>3.0.co;2-z · Cited by 102
Probst‐Kepper, M., Stroobant, V., Kridel, R., Gaugler, B., Landry, C., Brasseur, F., Cosyns, J., Weynand, B., Boon, T., & den Eynde, B. J. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.10.1189 · Cited by 102
Self-citationThe SSX Family of Cancer‐Testis Antigens as Target Proteins for Tumor Therapy
Smith, H. A., & McNeel, D. G. (2010) · Journal of Immunology Research · doi:10.1155/2010/150591 · Cited by 101
Carrasco, J., Pel, A. V., Neyns, B., Lethé, B., Brasseur, F., Renkvist, N., van der Bruggen, P., van Baren, N., Paulus, R., Thielemans, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3585 · Cited by 99
Self-citationLucas, S., Plaen, E. D., & Boon, T. (2000) · International Journal of Cancer · Cited by 96
Self-citationMaryanski, J. L., Snick, J. V., Cerottini, J., & Boon, T. (1982) · European Journal of Immunology · doi:10.1002/eji.1830120508 · Cited by 88
Self-citationMelanoma Antigen A4 Is Expressed in Non–Small Cell Lung Cancers and Promotes Apoptosis
Peikert, T., Specks, U., Farver, C. F., ERZURUM, S. C., & COMHAIR, S. A. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3327 · Cited by 85
Analysis of the Processing of Seven Human Tumor Antigens by Intermediate Proteasomes
Guillaume, B., Stroobant, V., Bousquet, M., Colau, D., Chapiro, J., Parmentier, N., Dalet, A., & den Eynde, B. J. V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103213 · Cited by 82
Lucas, S., Brasseur, F., & Boon, T. (1999) · PubMed · Cited by 80
Self-citationZendman, A. J. W., van Kraats, A. A., Weidle, U. H., Ruiter, D. J., & van Muijen, G. N. P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10371 · Cited by 77
MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development
Gjerstorff, M. F., Kock, K., Nielsen, O., & Ditzel, H. J. (2007) · Human Reproduction · doi:10.1093/humrep/del494 · Cited by 71
An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members
Gjerstorff, M. F., & Ditzel, H. J. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00997.x · Cited by 66
Production of an antigenic peptide by insulin-degrading enzyme
Parmentier, N., Stroobant, V., Colau, D., de Diesbach, P., Morel, S., Chapiro, J., Endert, P. V., & den Eynde, B. J. V. (2010) · Nature Immunology · doi:10.1038/ni.1862 · Cited by 63
Brändle, D., Bilsborough, J., Rülicke, T., Uyttenhove, C., Boon, T., & den Eynde, B. J. V. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199812)28:12<4010::aid-immu4010>3.0.co;2-5 · Cited by 62
Self-citationSmith, H. A., Cronk, R. J., Lang, J. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2127 · Cited by 62
Panelli, M. C., Bettinotti, M. P., Lally, K. M., Ohnmacht, G. A., Li, Y., Robbins, P. F., Riker, A. I., Rosenberg, S. A., & Marincola, F. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4382 · Cited by 59
Major Histocompatibility Complex Expression on Human, Male Germ Cells: A Review
Fiszer, D., & Kurpisz, M. K. (1998) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1998.tb00409.x · Cited by 59
Frequent DNA hypomethylation of human juxtacentromericBAGE loci in cancer
Grunau, C., Sánchez, C. G., Ehrlich, M., van der Bruggen, P., Hindermann, W., Rodríguez, C., Krieger, S., Dubeau, L., Fiala, E. S., & Sario, A. D. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20155 · Cited by 56
Rouse, B. T., Röllinghoff, M., & Warner, N. L. (1972) · Nature New Biology · doi:10.1038/newbio238116a0 · Cited by 56
Khammari, A., Nguyen, J., Pandolfino, M. C., Quereux, G., Brocard, A., Bercegeay, S., Cassidanius, A., Lemarre, P., Volteau, C., Labarrière, N., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0340-1 · Cited by 52
Ruault, M., van der Bruggen, P., Brun, M.-E., Boyle, S., Roizès, G., & Sario, A. D. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200891 · Cited by 48
Peptide database of T-cell defined tumor antigens
van der Bruggen, P., Stroobant, V., Vigneron, N., & den Eynde, B. J. V. (2013) · Digital Access to Libraries · Cited by 46
Minimal Tolerance to a Tumor Antigen Encoded by a Cancer-Germline Gene
Huijbers, I. J., Soudja, S. M., Uyttenhove, C., Buferne, M., Inderberg, E. M., Colau, D., Pilotte, L., de Tenbossche, C. P., Chomez, P., Brasseur, F., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002612 · Cited by 34
Function of the A-Type Cyclins During Gametogenesis and Early Embryogenesis
Wolgemuth, D. J. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-19065-0_17 · Cited by 31
Yun, C., Senju, S., Fujita, H., Tsuji, Y., Irie, A., Matsushita, S., & Nishimura, Y. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.540206.x · Cited by 28
Newly Emerging Therapies Targeting Viral-Related Lymphomas
Ramos, J. C., & Lossos, I. S. (2011) · Current Oncology Reports · doi:10.1007/s11912-011-0186-8 · Cited by 26
Induced malignant genome reprogramming in somatic cells by testis-specific factors
Wang, J., Emadali, A., Bescont, A. L., Callanan, M. B., Rousseaux, S., & Khochbin, S. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.04.003 · Cited by 24
Ruault, M., Ventura, M., Galtier, N., Brun, M.-E., Archidiacono, N., Roizès, G., & Sario, A. D. (2003) · Genomics · doi:10.1016/s0888-7543(03)00025-9 · Cited by 23
Genes Coding for Tumor-specific Rejection AntigensPreprint
Boon, T., den Eynde, B. J. V., Hirsch, H., Moroni, C., Plaen, E. D., van der Bruggen, P., Smet, C. D., Lurquin, C., Szikora, J., & Backer, O. D. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.070 · Cited by 17
Self-citationPark, H. J., Seo, H.-J., Kim, H., Kim, J. S., Hwang, S.-Y., & Seong, Y. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.90 · Cited by 9
Cited by
Radiomics: the bridge between medical imaging and personalized medicine
Lambin, P., Leijenaar, R. T. H., Deist, T. M., Peerlings, J., de Jong, E. E. C., van Timmeren, J., Sanduleanu, S., Larue, R. T. H. M., Even, A. J. G., Jochems, A., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.141 · Cited by 5,688
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
Metadata
- Authors
- Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T.
- Venue
- Nature Reviews Cancer
- Published
- 2014-01-24
- Volume
- 14
- Issue
- 2
- Pages
- 135-146
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2062398277
- Cited by
- 1,138
- References
- 160
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.